Literature DB >> 20214041

A small interference RNA screen revealed proteasome inhibition as strategy for glioblastoma therapy.

Kimberly Ng1, Masayuki Nitta, Lauren Hu, Santosh Kesari, Andrew Kung, Alan D'Andrea, Clark C Chen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20214041

Source DB:  PubMed          Journal:  Clin Neurosurg        ISSN: 0069-4827


× No keyword cloud information.
  5 in total

1.  miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients.

Authors:  Johnny C Akers; Valya Ramakrishnan; Ryan Kim; Shirley Phillips; Vivek Kaimal; Ying Mao; Wei Hua; Isaac Yang; Chia-Chun Fu; John Nolan; Ichiro Nakano; Yuanfan Yang; Martin Beaulieu; Bob S Carter; Clark C Chen
Journal:  J Neurooncol       Date:  2015-04-23       Impact factor: 4.130

Review 2.  DNA damage response and repair: insights into strategies for radiation sensitization of gliomas.

Authors:  Santosh Kesari; Sunil J Advani; Joshua D Lawson; Kristopher T Kahle; Kimberly Ng; Bob Carter; Clark C Chen
Journal:  Future Oncol       Date:  2011-11       Impact factor: 3.404

3.  Bortezomib overcomes MGMT-related resistance of glioblastoma cell lines to temozolomide in a schedule-dependent manner.

Authors:  Panagiotis J Vlachostergios; Eleana Hatzidaki; Christina D Befani; Panagiotis Liakos; Christos N Papandreou
Journal:  Invest New Drugs       Date:  2013-05-05       Impact factor: 3.850

4.  Efficacy of low dose temozolomide in combination with bortezomib in U87 glioma cells: a flow cytometric analysis.

Authors:  Panagiotis J Vlachostergios; Christos N Papandreou
Journal:  Arch Med Sci       Date:  2013-08-12       Impact factor: 3.318

5.  MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development.

Authors:  Johnny C Akers; Valya Ramakrishnan; Ryan Kim; Johan Skog; Ichiro Nakano; Sandeep Pingle; Juliya Kalinina; Wei Hua; Santosh Kesari; Ying Mao; Xandra O Breakefield; Fred H Hochberg; Erwin G Van Meir; Bob S Carter; Clark C Chen
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.